- Report
- April 2025
- 50 Pages
Global
From €2409EUR$2,650USD£2,062GBP
Bromazine is a respiratory drug used to treat asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. It is a bronchodilator, meaning it helps to open up the airways and make breathing easier. Bromazine is available in both oral and inhaled forms, and is often used in combination with other medications. It is generally considered to be a safe and effective treatment for respiratory conditions.
The bromazine market is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include GlaxoSmithKline, Merck, Pfizer, AstraZeneca, and Novartis. These companies offer a variety of bromazine products, ranging from generic versions to branded products. Additionally, there are many smaller companies that offer generic versions of the drug. Show Less Read more